Eli Lilly caps insulin cost at $35 per month amid COVID-19 pandemic

( By Alia Paavola for Becker’s Hospital Review)

Eli Lilly is capping the out-of-pocket cost for insulin at $35 per month in an effort to help patients afford the drug amid the COVID-19 pandemic.

The new $35 copay cap, effective April 7, covers most of Eli Lilly’s insulins, including its Humalog injection.  Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.